Search

everythinglearnresearchcommunity

for

Search:↓

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Betulinic acid can help treat hepatitis C by stopping virus replication.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Demodex folliculitis can occur in HIV patients on HAART, and treatment may involve topical creams or medication changes.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Infectious virus was not found after the third remdesivir dose, suggesting early end of isolation is possible.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Five FDA-approved drugs may help block COVID-19 virus entry.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

A blood pressure drug, diltiazem, may also help treat influenza.

Dutasteride reduces DHT more effectively than finasteride.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

New tests detect finasteride and dutasteride in urine quickly and easily.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

CTP-543 is generally safe for treating alopecia areata.